Organigram going all in on synthetic cannabinoid investment

Moncton NB-based Organigram Holdings Inc. (OGI) (TSE.OGI) announced Friday it is providing an additional $2.5 million investment in biotechnology company Hyasynth Biologicals to assist in furthering the production of biosynthetic cannabinoids.

OGI made an initial $5 million investment in Hyas…

For further details see:


Organigram going all in on synthetic cannabinoid investment